TrialBritish journal of cancer2015

A randomised phase II trial of selumetinib vs selumetinib plus temsirolimus for soft-tissue sarcomas.

Z Eroglu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.